Abstract
Introduction To date, anticipatory planning in the UK has focused on supporting people who anticipate periods of impaired decisional capacity to express their wishes about their future care through processes such as advance care planning. Other countries have extended anticipatory planning to include mechanisms for people to prospectively express their preferences about research participation. Advance research planning (ARP) could extend people’s autonomy and ensure that ‘proxy’ decisions about research are based on their wishes and preferences.
Objectives To explore a range of public and professional stakeholders’ views about the acceptability and feasibility of planning for future research participation and identify barriers and facilitators to implementing ARP.
Design Cross-sectional survey
Main outcomes Acceptability and feasibility of ARP
Participants Between November 2022 and March 2023, two groups of stakeholders (members of the public including people living with capacity-affecting conditions and their carers; researchers and other professionals) were invited to participate in a cross-sectional survey via multiple recruitment routes. Online questionnaires were used to capture the perspectives of the two groups.
Results Responses from members of the public (n=277) and professionals (n=50) were analysed using descriptive statistics and content analysis. Introducing ARP in the UK was supported by 97% of public contributors and 94% of professionals, who recommended it include the person’s general wishes about research, specific types of studies if known, and who should make decisions on their behalf. Challenges include how ARP takes account of changes in individuals’ preferences or circumstances and protecting their rights and interests. Implementation barriers include the potential time, complexity, and cost involved. These may be addressed by embedding ARP in existing anticipatory planning pathways and aligning it with other research enrolment activities. Relationships and trust have a key role, including underpinning who supports the delivery of ARP, how they are trained, and when it is undertaken.
Conclusions There are high levels of support for implementing ARP in the UK. Further research should explore practical barriers and stakeholder concerns and identify any unintended consequences. ARP interventions should be developed alongside training and other resources. Activities should focus on public awareness campaigns, and engaging policymakers and other stakeholders.
Strengths and limitations of this study
This is the first exploration of the acceptability and feasibility of advance research planning in the UK
Questions were based on previous similar surveys conducted in other countries which ensured prior validation and enables international comparison
The study included a wide range of members of the public including people living with conditions that may affect decision-making in the future, and professionals including researchers, research ethics committee members, and healthcare practitioners
The non-random selection of participants and inability to track non-responders may have resulted in potential participation bias
Participants were predominantly white and had some prior involvement in research, therefore their views may not be representative of more diverse groups or those with less experience of research
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was conducted as part of a National Institute of Health Research Advanced Fellowship (CONSULT) held by VS and funded by the Welsh Government through Health and Care Research Wales (NIHR-FS(A)-2021)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
School of Medicine Research Ethics Committee of Cardiff University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The dataset generated and used in this study is available through submission of a data request to the Centre for Trials Research at https://www.cardiff.ac.uk/centre-for-trials-research/about-us/data-requests